EUVIMEDEUVIMED entdecken
Crossref

Current Status of Pig-to-NHP Xenotransplantation Research in Korea

Sun Ae Hwang, Sangil Min, Ki Cheul Shin, Hyun Keun Chee, Wan Seop Kim, Young Rok Choi, Hyun Suk Yang, Yu Rim Ahn, Jeong Ho Hwang, Hyunil Kim, Keon Bong Oh, Ik Jin Yun

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.05.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Sun Ae Hwang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Konkuk University School of Medicine, Seoul, Korea; Institute for Experiments of Non-clinical NHP Solid Organ Xenotransplantat…. Hauptthemen laut MEDLINE: Transplantation, Heterologous. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Xenotransplantation has the potential to mitigate the shortage of transplantable organs in Korea. However, its clinical application is yet to be established. Preclinical studies using non-human primates (NHPs) are required, as these animal models may yield excellent results. Therefore, we aimed to investigate the progress in pig-to-NHP xenotransplantation research in Korea and identify alternative approaches for the clinical application of human xenotransplantation. METHODS: We investigated the use of transgenic pigs developed by Optipharm (8; QKO+CD39+CD55+CD46+TBM) and the National Institute of Animal Science (4; GTKO, CMAH, HO1, and CD47) for xenotransplantation in Korea. We further analyzed the outcomes of 100 pig-to-NHP xenotransplantation performed by our xenotransplantation research team since 2011. These included 42, 34, 3, and 21 kidney, heart, liver, and partial corneal transplants, respectively. In addition, the immunosuppressants used were anti-CD154, rituximab, anti-thymocyte globulin, rapamycin, and tacrolimus. RESULTS: The longest survival duration was 221, 217, and 1422 d for the kidney, heterotopic heart, and parietal corneal transplants, respectively. In contrast, the survival duration did not exceed 1 d in cases of liver transplantation. Furthermore, some immunosuppressants and anticoagulants exhibited the potential to improve clinical outcomes. These drugs have become clinically available and have functionally improved since their development. CONCLUSIONS: Our findings indicate that the clinical application of xenografts in Korea depends on the development of multiple transgenic pigs and further development of immunosuppressants and anticoagulants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousAnimalsAnimals, Genetically ModifiedHumansRepublic of KoreaSwineImmunosuppressive AgentsGraft SurvivalGraft Rejection

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Surgery, Konkuk University School of Medicine, Seoul, Korea; Institute for Experiments of Non-clinical NHP Solid Organ Xenotransplantation, Konkuk University School of Medicine, Seoul, Korea.
  • Institute for Experiments of Non-clinical NHP Solid Organ Xenotransplantation, Konkuk University School of Medicine, Seoul, Korea; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
  • Institute for Experiments of Non-clinical NHP Solid Organ Xenotransplantation, Konkuk University School of Medicine, Seoul, Korea; Department of Ophthalmology, Konkuk University Medical Center, Seoul, Korea.
  • Institute for Experiments of Non-clinical NHP Solid Organ Xenotransplantation, Konkuk University School of Medicine, Seoul, Korea; Department of Thoracic Surgery, Konkuk University Hospital, Seoul, Korea.
  • Institute for Experiments of Non-clinical NHP Solid Organ Xenotransplantation, Konkuk University School of Medicine, Seoul, Korea; Department of Pathology, Konkuk University School of Medicine, Seoul, Korea.
  • Department of Surgery, Seoul National University Bundang Hospital, Seoul, Korea.

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Hwang, S. A., Min, S., Shin, K. C., Chee, H. K., Kim, W. S., Choi, Y. R., Yang, H. S., Ahn, Y. R., Hwang, J. H., Kim, H., Oh, K. B., & Yun, I. J. (2025). Current Status of Pig-to-NHP Xenotransplantation Research in Korea. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.05.004

Vancouver

Hwang SA, Min S, Shin KC, Chee HK, Kim WS, Choi YR, et al. Current Status of Pig-to-NHP Xenotransplantation Research in Korea. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.05.004

BibTeX
@article{Hwang2025,
  author = {Hwang, Sun Ae and Min, Sangil and Shin, Ki Cheul and Chee, Hyun Keun and Kim, Wan Seop and Choi, Young Rok and Yang, Hyun Suk and Ahn, Yu Rim and Hwang, Jeong Ho and Kim, Hyunil and Oh, Keon Bong and Yun, Ik Jin},
  title = {Current Status of Pig-to-NHP Xenotransplantation Research in Korea},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.05.004}
}
Kostenlos starten →